Seres Therapeutics (MCRB)

7.76 -0.16 (2.02%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/7/18 *Est.)

Latest Headlines

Form 4 Seres Therapeutics, Inc. For: May 15 Filed by: Aunins John G. September 19, 2018 9:23 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Sep 07 Filed by: Pomerantz Roger September 11, 2018 4:51 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Sep 05 Filed by: Pomerantz Roger September 6, 2018 5:10 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Aug 30 Filed by: Zausner Meryl September 4, 2018 4:50 PM - SEC Filing Form 3 Seres Therapeutics, Inc. For: Aug 30 Filed by: Zausner Meryl September 4, 2018 4:44 PM - SEC Filing Form 8-K Seres Therapeutics, Inc. For: Aug 30 September 4, 2018 7:50 AM - SEC Filing Seres Therapeutics (MCRB) Appoints Meryl Zausner to Board September 4, 2018 7:11 AM - StreetInsider Seres Therapeutics Strengthens Board of Directors with Appointment of Meryl Zausner, Experienced Biopharmaceutical Financial Leader September 4, 2018 7:00 AM - BizWire The Microbiome Therapeutics Innovation Group Announces Coalition Formation and Leadership Team August 14, 2018 10:07 AM - PR NewsWire Form 8-K Seres Therapeutics, Inc. For: Aug 07 August 7, 2018 1:07 PM - SEC Filing Seres Therapeutics (MCRB) PT Lowered to $17 at Oppenheimer August 3, 2018 9:25 AM - StreetInsider BofA/Merrill Lynch Downgrades Seres Therapeutics (MCRB) to Underperform August 3, 2018 6:10 AM - StreetInsider Form 10-Q Seres Therapeutics, Inc. For: Jun 30 August 2, 2018 11:38 AM - SEC Filing Seres Therapeutics (MCRB) Misses Q2 EPS by 5c, Revenues Miss August 2, 2018 7:20 AM - StreetInsider Form 8-K Seres Therapeutics, Inc. For: Aug 02 August 2, 2018 7:09 AM - SEC Filing Seres Therapeutics Reports Second Quarter Financial Results and Provides Operational Updates August 2, 2018 7:00 AM - BizWire Seres Therapeutics to Host Second Quarter 2018 Financial Results and Operational Progress Conference Call and Webcast on August 2, 2018 July 25, 2018 4:27 PM - BizWire Form 4 Seres Therapeutics, Inc. For: Jul 16 Filed by: Aunins John G. July 18, 2018 4:59 PM - SEC Filing Flagship Pioneering Unveils Inari Agriculture July 18, 2018 8:00 AM - PR NewsWire Form 4 Seres Therapeutics, Inc. For: Jul 11 Filed by: Pomerantz Roger July 12, 2018 5:16 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jul 06 Filed by: Pomerantz Roger July 10, 2018 5:49 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jun 28 Filed by: Pomerantz Roger June 29, 2018 5:13 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jun 26 Filed by: Dere Willard H June 27, 2018 9:08 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jun 25 Filed by: Pomerantz Roger June 27, 2018 9:07 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jun 26 Filed by: Kender Richard N June 27, 2018 9:07 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jun 26 Filed by: Kim Lorence H. June 27, 2018 9:07 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jun 26 Filed by: AFEYAN NOUBAR June 27, 2018 9:05 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jun 26 Filed by: Behar Gregory June 27, 2018 9:04 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jun 26 Filed by: Ausiello Dennis A June 27, 2018 9:03 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Jun 26 Filed by: Graves Kurt June 27, 2018 9:03 PM - SEC Filing Form 8-K Seres Therapeutics, Inc. For: Jun 26 June 27, 2018 4:35 PM - SEC Filing Full Article List